DE20202562U1 - Micronutrient combination product with probiotics and prebiotics - Google Patents

Micronutrient combination product with probiotics and prebiotics

Info

Publication number
DE20202562U1
DE20202562U1 DE20202562U DE20202562U DE20202562U1 DE 20202562 U1 DE20202562 U1 DE 20202562U1 DE 20202562 U DE20202562 U DE 20202562U DE 20202562 U DE20202562 U DE 20202562U DE 20202562 U1 DE20202562 U1 DE 20202562U1
Authority
DE
Germany
Prior art keywords
vitamin
probiotics
combination product
lactobacillus
micronutrient combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE20202562U
Other languages
German (de)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orthomol Pharmazeutische Vertriebsgesellschaft mbH
Original Assignee
Orthomol Pharmazeutische Vertriebsgesellschaft mbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orthomol Pharmazeutische Vertriebsgesellschaft mbH filed Critical Orthomol Pharmazeutische Vertriebsgesellschaft mbH
Priority to DE20202562U priority Critical patent/DE20202562U1/en
Publication of DE20202562U1 publication Critical patent/DE20202562U1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Description

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßt The description text was not recorded electronically  

Der Beschreibungstext wurde nicht elektronisch erfaßtThe description text was not recorded electronically

Claims (16)

1. Probiotika enthaltendes Mikronährstoffkombinationsprodukt, dadurch gekennzeichnet, dass das Mikronährstoffkombinationsprodukt mindestens zwei Produktanteile mit unterschiedlicher Zusammensetzung umfasst, wobei ein erster Anteil als wirksame Bestandteile Probiotika umfasst und der zweite Anteil als wirksame Bestandteile Prebiotika, Spurenelemente, Vitamine und sekundäre Pflanzenstoffe umfasst.1. A micronutrient combination product containing probiotics, characterized in that the micronutrient combination product comprises at least two product portions with different compositions, a first portion comprising probiotics as active ingredients and the second portion comprising prebiotics, trace elements, vitamins and secondary plant substances as active ingredients. 2. Probiotika enthaltendes Mikronährstoffkombinationsprodukt nach Anspruch 1, dadurch gekennzeichnet, dass die probiotischen Kulturen ausgewählt sind aus der Gruppe umfassend Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus crispatus, Lactobacillus gallinarum, Lactobacillus gasseri, Lactobacillus johnsonii, Lactobacillus paracasei, Lactobacillus plantarum, Lactobacillus reuteri, Lactobacillus rhamnosus, Lactobacillus salivarius, Bifidobacterium adolescentis, Bifidobacterium animalis, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium lactis, Bifidobacterium longum, Enterococcus faecalis, Enterococcus faecium, Lactococcus lactis, Leuc. mesenteroides, Ped. acidilactici, Sporolactobacillus inulinus, Strep. thermophilus, Bacillus cereus, Escherichia coli, Propionibacterium freudenreichii und/oder Saccharomyces cerevisiae, vorzugsweise Bifidobacterium lactis, Bifidobacterium animalis, Lactococcus lactis, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus salivarius und/oder Enterococcus faecium.2. The micronutrient combination product containing probiotics according to claim 1, characterized in that the probiotic cultures are selected from the group comprising Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus crispatus, Lactobacillus gallinarum, Lactobacillus gasseri, Lactobacillus johnsonii, Lactobacillus paracasei, Lactobacillus plantarum, Lactobacillus reuteri, Lactobacillus rhamnosus, Lactobacillus salivarius, Bifidobacterium adolescentis, Bifidobacterium animalis, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium lactis, Bifidobacterium longum, Enterococcus faecalis, Enterococcus faecium, Lactococcus lactis, Leuc. mesenteroides, Ped. acidilactici, Sporolactobacillus inulinus, Strep. thermophilus Bacillus cereus, Escherichia coli, Propionibacterium freudenreichii and / or Saccharomyces cerevisiae, preferably Bifidobacterium lactis, Bifidobacterium animalis, Lactococcus lactis, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus salivarius and / or Enterococcus faecium. 3. Probiotika enthaltendes Mikronährstoffkombinationsprodukt nach Anspruch 1 oder 2, dadurch gekennzeichnet, dass die Kombination Enterococcus faecium und Milchsäurebakterien besonders bevorzugt ist. 3. The probiotics-containing micronutrient combination product according to claim 1 or 2, characterized in that the combination Enterococcus faecium and Lactic acid bacteria is particularly preferred.   4. Probiotika enthaltendes Mikronährstoffkombinationsprodukt nach einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass die Prebiotika ausgewählt sind aus der Gruppe umfassend Inulin, Fructooligosaccharide und β-Glucan.4. Probiotics-containing micronutrient combination product according to one of the previous claims, characterized in that the prebiotics are selected from the Group comprising inulin, fructooligosaccharides and β-glucan. 5. Probiotika enthaltendes Mikronährstoffkombinationsprodukt nach einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass die Vitamine ausgewählt sind aus der Gruppe umfassend Vitamin A, Vitamin C, natürliches Vitamin E, Vitamin B1, Vitamin B2, Niacin, Vitamin B6, Vitamin B12, Vitamin K1, Vitamin D3, Folsäure, Panthothensäure und/oder Biotin.5. Probiotics-containing micronutrient combination product according to one of the preceding claims, characterized in that the vitamins are selected from the group comprising vitamin A, vitamin C, natural vitamin E, vitamin B 1 , vitamin B 2 , niacin, vitamin B 6 , vitamin B 12 , Vitamin K 1 , vitamin D 3 , folic acid, pantothenic acid and / or biotin. 6. Probiotika enthaltendes Mikronährstoffkombinationsprodukt nach einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass die Spurenelemente ausgewählt sind aus der Gruppe umfassend Calcium, Selen, Eisen, Zink, Mangan, Kupfer, Chrom, Molybdän, Iod, Phosphor, Magnesium, Kalium und/oder Chlorid, vorzugsweise Selen, Eisen, Zink, Mangan, Kupfer, Chrom, Molybdän und/oder Iod.6. Micronutrient combination product containing probiotics according to one of the previous claims, characterized in that the trace elements are selected from the group comprising calcium, selenium, iron, zinc, manganese, copper, chromium, molybdenum, Iodine, phosphorus, magnesium, potassium and / or chloride, preferably selenium, iron, zinc, Manganese, copper, chromium, molybdenum and / or iodine. 7. Probiotika enthaltendes Mikronährstoffkombinationsprodukt nach einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass sekundären Pflanzenstoffe ausgewählt sind aus der Gruppe umfassend Carotinoide, wie Beta-Carotin, Alpha-Carotin, Lykopin und Lutein sowie Bioflavonoide wie Citrus-Bioflavonoide.7. Probiotics-containing micronutrient combination product according to one of the previous claims, characterized in that secondary plant substances selected are from the group comprising carotenoids such as beta-carotene, alpha-carotene, lycopene and Lutein and bioflavonoids such as citrus bioflavonoids. 8. Probiotika enthaltendes Mikronährstoffkombinationsprodukt nach einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass der Anteil des Probiotika enthaltenden Mikronährstoffkombinationsprodukts fest-, flüssig und/oder gelförmig vorliegen.8. Micronutrient combination product containing probiotics according to one of the previous claims, characterized in that the proportion of probiotics containing micronutrient combination product in solid, liquid and / or gel form available. 9. Probiotika enthaltendes Mikronährstoffkombinationsprodukt nach einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass das Mikronährstoffkombinationsprodukt in Form wenigstens zwei getrennt vorliegender Produktanteile, vorzugsweise in Form wenigstens drei getrennt vorliegender Produktanteile und besonders bevorzugt in Form wenigstens vier getrennt vorliegender Produktanteile vorliegt, wobei ein erster Produktanteil als wirksame Bestandteile Probiotika umfasst und ein zweiter Produktanteil als wirksame Bestandteile Prebiotika umfasst.9. Probiotics-containing micronutrient combination product according to one of the previous claims, characterized in that the  Micronutrient combination product in the form of at least two separately available Product parts, preferably in the form of at least three separate product parts and particularly preferably in the form of at least four separate product parts is present, a first product portion comprising probiotics as active ingredients and a second part of the product includes prebiotics as active ingredients. 10. Probiotika enthaltendes Mikronährstoffkombinationsprodukt nach einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass das Probiotika enthaltende Mikronährstoffkombinationsprodukt umfassend wenigstens zwei Anteile mit unterschiedlicher Zusammensetzung in Form von 0 bis 10 Tabletten, bevorzugt 1 bis 5 Tabletten, 0 bis 10 Kapseln, bevorzugt 1 bis 5 Kapseln, 0 bis 5 Lösungen, bevorzugt 1 bis 2 Lösungen und/oder 0 bis 5 Granulate, bevorzugt 1 bis 3 Granulate, vorliegt.10. Probiotics-containing micronutrient combination product according to one of the previous claims, characterized in that the probiotics containing Micronutrient combination product comprising at least two portions with different compositions in the form of 0 to 10 tablets, preferably 1 to 5 Tablets, 0 to 10 capsules, preferably 1 to 5 capsules, 0 to 5 solutions, preferably 1 to 2 Solutions and / or 0 to 5 granules, preferably 1 to 3 granules, are present. 11. Probiotika enthaltendes Mikronährstoffkombinationsprodukt nach einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass das Probiotika enthaltende Mikronährstoffkombinationsprodukt wenigstens ein getrennt vorliegendes erstes Produkt umfassend als wirksame Bestandteile probiotische Kulturen, vorzugsweise Bifidobacterium lactis, Bifidobacterium animalis, Lactococcus lactis, Enterococcus faecium, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus salivarius; und wenigstens ein zweites getrennt vorliegendes Produkt umfassend als wirksame Bestandteile Vitamin A, Vitamin C, Vitamin E, Vitamin B1, Vitamin B2, Niacin, Vitamin B6, Vitamin B12, Vitamin K1, Vitamin D3, Folsäure, Pantothensäure, Biotin, Selen, Eisen, Zink, Mangan, Kupfer, Chrom, Molybdän, Iod, Carotinoide, Bioflavonoide, Inulin umfasst.11. The probiotics-containing micronutrient combination product according to one of the preceding claims, characterized in that the probiotics-containing micronutrient combination product comprises at least one separately available first product comprising, as active ingredients, probiotic cultures, preferably Bifidobacterium lactis, Bifidobacterium animalis, Lactococcus lactis, Enterococcus faecium, Lactobacus lactacillus acid , Lactobacillus salivarius; and at least one second separate product comprising as active ingredients vitamin A, vitamin C, vitamin E, vitamin B 1 , vitamin B 2 , niacin, vitamin B 6 , vitamin B 12 , vitamin K 1 , vitamin D 3 , folic acid, pantothenic acid, Includes biotin, selenium, iron, zinc, manganese, copper, chromium, molybdenum, iodine, carotenoids, bioflavonoids, inulin. 12. Probiotika enthaltendes Mikronährstoffkombinationsprodukt nach einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass das Probiotika enthaltende Mikronährstoffkombinationsprodukt Zusätze aufweist, die die Bioverfligbarkeit, Löslichkeit und/oder Lösegeschwindigkeit verbessern und/oder Zusätze, ausgewählt aus der Gruppe umfassend Sprengmittel, Stoffe die die Haltbarkeit verbessern, geschmacksmaskierende und/oder geschmacksverbessernde Stoffe, Stoffe zur Erhöhung oder Senkung der Viskosität, aufweist.12. The micronutrient combination product containing probiotics according to one of the previous claims, characterized in that the probiotics containing Micronutrient combination product has additives that have bioavailability, solubility and / or improve dissolving speed and / or additives selected from the group  including explosives, substances that improve durability, taste masking and / or taste-improving substances, substances to increase or decrease the viscosity, having. 13. Probiotika enthaltendes Mikronährstoffkombinationsprodukt nach einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass das Probiotika enthaltende Mikronährstoffkombinationsprodukt Zusätze, ausgewählt aus der Gruppe umfassend Dextrose, Maltodextrin, Inulin, Maisstärke, natürliches Orangenaroma, Säuerungsmittel Zitronensäure, Gummi Arabicum, Fructooligosaccharide, Saccharin-Natrium und/oder Enzyme umfasst.13. A micronutrient combination product containing probiotics according to one of the previous claims, characterized in that the probiotics containing Micronutrient combination product additives selected from the group consisting of Dextrose, maltodextrin, inulin, corn starch, natural orange aroma, acidulant Citric acid, gum arabic, fructooligosaccharides, saccharin sodium and / or Encompasses enzymes. 14. Probiotika enthaltendes Mikronährstoffkombinationsprodukt nach einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass das erste getrennt vorliegende Produkt, bezogen auf eine Tagesdosis, 2 × 109 KBE probiotische Kulturen umfasst und das zweite getrennt vorliegende Produkt, bezogen auf eine Tagesdosis, 0,3-0,5 g Vitamine, 9-11 mg Spurenelemente, 2 g Prebiotika und 20-30 mg sekundärer Pflanzenstoffe umfasst.14. The micronutrient combination product containing probiotics according to one of the preceding claims, characterized in that the first separate product, based on a daily dose, comprises 2 × 10 9 CFU probiotic cultures and the second separate product, based on a daily dose, 0.3- 0.5 g vitamins, 9-11 mg trace elements, 2 g prebiotics and 20-30 mg phytochemicals. 15. Probiotika enthaltendes Mikronährstoffkombinationsprodukt nach einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass das erste getrennt vorliegende Produkt als wirksame Bestandteile, bezogen auf eine Tagesdosis:
  • a) 5 × 108-5 × 109 KBE, bevorzugt 1-3 × 109 KBE, probiotische Kulturen ausgewählt aus der Gruppe umfassend Bifidobacterium lactis Bifdobacterium animalis, Lactococcus lactis, Enterococcus faecium, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus salivarius;
umfasst, und
das zweite getrennt vorliegende Produkt, bezogen auf eine Tagesdosis, als wirksame Bestandteile die Stoffe umfasst:
  • a) 1000-4000 IE, bevorzugt 2000-3000 IE, Vitamin A;
  • b) 100-500 mg, bevorzugt 200-400 mg, Vitamin C;
  • c) 10-80 mg, bevorzugt 25-45 mg, natürliches Vitamin E;
  • d) 1-6 mg, bevorzugt 2-4 mg, Vitamin B1;
  • e) 1-7 mg, bevorzugt 3-4 mg, Vitamin B2;
  • f) 10-80 mg, bevorzugt 25-45 mg, Niacin;
  • g) 1-7 mg, bevorzugt 3-4 mg Vitamin B6;
  • h) 1-10 µg, bevorzugt 3-7 µg, Vitamin B12;
  • i) 10-100 µg, bevorzugt 30-70 µg, Vitamin K1;
  • j) 1-10 µg, bevorzugt 4-6 µg, Vitamin D3;
  • k) 200-1000 µg, bevorzugt 400-800 µg, Folsäure;
  • l) 5-50 mg, bevorzugt 10-25 mg, Panthothensäure;
  • m) 50-300 µg, bevorzugt 150-225 µg; Biotin;
  • n) 5-80 µg, bevorzugt 20-50 µg, Selen;
  • o) 0,5-10 mg, bevorzugt 1-4 mg, Eisen;
  • p) 3-15 mg, bevorzugt 5-10 mg, Zink;
  • q) 0,3-3 mg, bevorzugt 0,5-2 mg, Mangan;
  • r) 0,2-3 mg, bevorzugt 0,4-2 mg, Kupfer;
  • s) 10-100 µg, bevorzugt 20-50 µg, Chrom;
  • t) 10-100 µg, bevorzugt 30-60 µg, Molybdän;
  • u) 50-200 µg, bevorzugt 100-150 µg, Iod;
  • v) 1-15 mg, bevorzugt 3-7 mg, Carotinoide;
  • w) 5-50 mg, bevorzugt 15-30 mg, Bioflavonoide;
  • x) 1-6 g, bevorzugt 2-4 g, Inulin.
15. The micronutrient combination product containing probiotics according to one of the preceding claims, characterized in that the first product present separately as active ingredients, based on a daily dose:
  • a) 5 × 10 8 -5 × 10 9 CFU, preferably 1-3 × 10 9 CFU, probiotic cultures selected from the group comprising Bifidobacterium lactis Bifdobacterium animalis, Lactococcus lactis, Enterococcus faecium, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus salivarius;
includes, and
the second separate product, based on a daily dose, comprises the following as active ingredients:
  • a) 1000-4000 IU, preferably 2000-3000 IU, vitamin A;
  • b) 100-500 mg, preferably 200-400 mg, vitamin C;
  • c) 10-80 mg, preferably 25-45 mg, natural vitamin E;
  • d) 1-6 mg, preferably 2-4 mg, vitamin B 1 ;
  • e) 1-7 mg, preferably 3-4 mg, vitamin B 2 ;
  • f) 10-80 mg, preferably 25-45 mg, niacin;
  • g) 1-7 mg, preferably 3-4 mg of vitamin B 6 ;
  • h) 1-10 µg, preferably 3-7 µg, vitamin B 12 ;
  • i) 10-100 µg, preferably 30-70 µg, vitamin K 1 ;
  • j) 1-10 µg, preferably 4-6 µg, vitamin D 3 ;
  • k) 200-1000 µg, preferably 400-800 µg, folic acid;
  • l) 5-50 mg, preferably 10-25 mg, pantothenic acid;
  • m) 50-300 µg, preferably 150-225 µg; biotin;
  • n) 5-80 µg, preferably 20-50 µg, selenium;
  • o) 0.5-10 mg, preferably 1-4 mg, iron;
  • p) 3-15 mg, preferably 5-10 mg, zinc;
  • q) 0.3-3 mg, preferably 0.5-2 mg, manganese;
  • r) 0.2-3 mg, preferably 0.4-2 mg, copper;
  • s) 10-100 µg, preferably 20-50 µg, chromium;
  • t) 10-100 µg, preferably 30-60 µg, molybdenum;
  • u) 50-200 µg, preferably 100-150 µg, iodine;
  • v) 1-15 mg, preferably 3-7 mg, carotenoids;
  • w) 5-50 mg, preferably 15-30 mg, bioflavonoids;
  • x) 1-6 g, preferably 2-4 g, inulin.
16. Probiotika enthaltendes Mikronährstoftkombinationsprodukt nach einem der vorherigen Ansprüche, dadurch gekennzeichnet, dass das erste getrennt vorliegende Produkt als wirksame Bestandteile, bezogen auf eine Tagesdosis:
  • a) 2 × 109 KBE probiotische Kulturen ausgewählt aus der Gruppe umfassend Bifidobacterium Iactis, Bifidobacterium animalis, Lactococcus lactis, Enterococcus faecium, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus salivarius;
umfasst und das zweite getrennt vorliegende Produkt, bezogen auf eine Tagesdosis, als wirksame Bestandteile die Stoffe umfasst:
  • a) 2500 IE Vitamin A
  • b) 300 mg Vitamin C;
  • c) 36 mg natürliches Vitamin E;
  • d) 3 mg Vitamin B1;
  • e) 3,6 mg Vitamin B2;
  • f) 35 mg Niacin;
  • g) 3,6 mg Vitamin B6;
  • h) 6 µg Vitamin B12;
  • i) 60 µg Vitamin K1;
  • j) 5 µg Vitamin D3;
  • k) 800 µg Folsäure;
  • l) 18 mg Panthothensäure;
  • m) 180 µg Biotin;
  • n) 30 µg Selen;
  • o) 2 mg Eisen;
  • p) 7 mg Zink;
  • q) 500 g Mangan;
  • r) 500 kg Kupfer;
  • s) 30 µg Chrom;
  • t) 50 µg Molybdän;
  • u) 100 Mg Iod;
  • v) 5 mg Carotinoide;
  • w) 20 mg Bioflavonoide;
  • x) 2 g Inulin.
16. Probiotics-containing micronutrient combination product according to one of the preceding claims, characterized in that the first product present separately as active ingredients, based on a daily dose:
  • a) 2 × 10 9 CFU probiotic cultures selected from the group comprising Bifidobacterium Iactis, Bifidobacterium animalis, Lactococcus lactis, Enterococcus faecium, Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus salivarius;
and the second separate product, based on a daily dose, comprises the following as active ingredients:
  • a) 2500 IU of vitamin A.
  • b) 300 mg of vitamin C;
  • c) 36 mg of natural vitamin E;
  • d) 3 mg of vitamin B 1 ;
  • e) 3.6 mg of vitamin B 2 ;
  • f) 35 mg of niacin;
  • g) 3.6 mg of vitamin B 6 ;
  • h) 6 µg of vitamin B 12 ;
  • i) 60 µg of vitamin K 1 ;
  • j) 5 µg of vitamin D 3 ;
  • k) 800 µg folic acid;
  • l) 18 mg pantothenic acid;
  • m) 180 µg biotin;
  • n) 30 µg selenium;
  • o) 2 mg iron;
  • p) 7 mg zinc;
  • q) 500 g of manganese;
  • r) 500 kg of copper;
  • s) 30 µg chromium;
  • t) 50 µg molybdenum;
  • u) 100 mg iodine;
  • v) 5 mg carotenoids;
  • w) 20 mg of bioflavonoids;
  • x) 2 g inulin.
DE20202562U 2002-02-19 2002-02-19 Micronutrient combination product with probiotics and prebiotics Expired - Lifetime DE20202562U1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE20202562U DE20202562U1 (en) 2002-02-19 2002-02-19 Micronutrient combination product with probiotics and prebiotics

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE20202562U DE20202562U1 (en) 2002-02-19 2002-02-19 Micronutrient combination product with probiotics and prebiotics

Publications (1)

Publication Number Publication Date
DE20202562U1 true DE20202562U1 (en) 2002-05-23

Family

ID=7967982

Family Applications (1)

Application Number Title Priority Date Filing Date
DE20202562U Expired - Lifetime DE20202562U1 (en) 2002-02-19 2002-02-19 Micronutrient combination product with probiotics and prebiotics

Country Status (1)

Country Link
DE (1) DE20202562U1 (en)

Cited By (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004002501A1 (en) * 2002-06-26 2004-01-08 Calpis Co., Ltd. Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy
WO2004017979A2 (en) * 2002-08-16 2004-03-04 Finzelberg Gmbh & Co. Kg Medicament, food supplement, and fodder additive
WO2004032645A1 (en) * 2002-10-11 2004-04-22 Erber Aktiengesellschaft Food additive and/or drinking water additive for domestic animals
FR2851889A1 (en) * 2003-03-06 2004-09-10 Larena Sa Product for restoration of tolerance to antigens useful for dietary or food compositions for prevention of intolerance to alimentary antigens and nonpathogenic bacteria and disturbance of the integrity of the intestinal barrier
WO2004112507A1 (en) * 2003-06-23 2004-12-29 Nestec S.A. Infant or follow-on formula
WO2004112508A1 (en) * 2003-06-23 2004-12-29 Nestec S.A. Infant or follow-on formula
EP1492549A1 (en) * 2002-03-13 2005-01-05 Kibow Biotech, Inc. Compositions and methods for augmenting kidney function
EP1602377A1 (en) * 2003-03-07 2005-12-07 Aureo Co., Ltd. Composition containing beta-glucan and constipation-relieving drug, immunopotentiator and skin moistening agent using the composition
EP1607096A2 (en) * 2004-06-18 2005-12-21 Dietetics Pharma S.r.l. Nutraceutical composition containing milk enzymes useful as synbiotic
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
AT413334B (en) * 2002-12-23 2006-02-15 Belihart Josephine Medically usable solid dosage form comprises freeze-dried live lactic acid bacteria and an excipient powder mixture of inulin and lactose in the form of a directly compressed tablet
WO2005109175A3 (en) * 2004-05-05 2006-04-20 Lifescape Biosciences Inc Vitamin compositions and treatment methods for metabolic diseases and nutrient deficiencies
WO2006027745A3 (en) * 2004-09-09 2006-05-11 Warburton Technology Ltd Trace elements
WO2006054135A1 (en) * 2004-11-16 2006-05-26 Anidral S.R.L. Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality
EP1666050A1 (en) * 2003-08-26 2006-06-07 Obschestvo S Ogranichennoi Otvetstvennostyu Alef- Farma Use of enrerococcus faecium strains for curing hepatic insufficiency and for regenerating and intensifying metabolism in a liver
WO2006133472A1 (en) * 2005-06-14 2006-12-21 Erber Aktiengesellschaft Probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive and use thereof
WO2008071930A1 (en) 2006-12-11 2008-06-19 Danisco A/S Composition
EP1964570A1 (en) * 2007-03-02 2008-09-03 Bufe, Albrecht, Prof. Dr. med. Pharmaceutical compound to protect against allergies and inflammatory illnesses
EP2030642A1 (en) * 2006-05-26 2009-03-04 José Antonio Cruz Serrano Gelatinous protein foodstuff and process for its preparation
WO2009071578A1 (en) * 2007-12-03 2009-06-11 Probiotical S.P.A. Composition based on probiotic bacteria in association with a prebiotic and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of intestinal functionality
FR2933848A1 (en) * 2008-07-18 2010-01-22 Roquette Freres COMPOSITION OF SOLUBLE INDIGESTIBLE FIBERS AND EUKARYOTIC ORGANISMS HAVING POLYSACCHARIDE WAVES USED IN THE WELL-BEING FIELD
US7651680B2 (en) 2004-06-23 2010-01-26 L'oreal Methods and compositions for preventing and treating sensitive and dry skin
ITMI20090065A1 (en) * 2009-01-22 2010-07-23 Dietetics Pharma S R L NUTRACEUTICAL COMPOSITION CONTAINING USEFUL LACTICTS AS SYMBIOTIC.
EP2248430A3 (en) * 2005-02-15 2011-01-12 Barry R. Goldin A food containing a probiotic and an isolated beta-glucan and methods of use thereof
US7879363B2 (en) 1998-07-07 2011-02-01 Ritter Pharmaceuticals, Inc. Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
ITMI20092327A1 (en) * 2009-12-29 2011-06-30 Giuliani Spa PHARMACEUTICAL OR DIETETIC COMPOSITION FOR THE TREATMENT OF ATOPIA
EP2401925A1 (en) * 2010-06-29 2012-01-04 Rosebud AG Prebiotic product and manufacturing method
US8481299B2 (en) 2009-03-04 2013-07-09 L'oreal Use of probiotic microorganisms to limit skin irritation
US8486668B2 (en) 2009-02-24 2013-07-16 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8492124B2 (en) 2009-02-24 2013-07-23 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US9049884B2 (en) 2009-12-04 2015-06-09 Abbott Laboratories Methods of modulating inflammation in preterm infants using carotenoids
WO2015160314A1 (en) * 2014-04-16 2015-10-22 SCHWARTZ, I. Sandford Nutraceutical blend for the enhancement of the immune system
WO2016035043A1 (en) * 2014-09-04 2016-03-10 SMITH, Jerome Shelsley Probiotic composition
US9375444B2 (en) 2008-08-16 2016-06-28 Protectimmun Gmbh Composition for prevention and treatment of allergic and/or inflammatory diseases
EP3275439A1 (en) * 2016-07-29 2018-01-31 Medday Pharmaceuticals Method for treating hepatic encephalopathy
EP3318263A1 (en) * 2016-11-03 2018-05-09 Cell Biotech Co., Ltd. Antioxidant composition and composition for improvement of skin conditions
US10172793B2 (en) 2003-12-24 2019-01-08 Ferrosan A.S. Probiotic tablet formulations
US10238897B2 (en) 2007-09-04 2019-03-26 L'oreal Use of a lysate of bifidobacterium species for treating sensitive skin
US11154731B2 (en) 2007-09-04 2021-10-26 L'oreal Cosmetic use of Bifidobacterium species lysate for the treatment of dryness
WO2022090335A1 (en) * 2020-10-28 2022-05-05 Dsm Ip Assets B.V. Direct delivery of vitamins to rebalance gut microbiome after exposure to antibiotics

Cited By (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7879363B2 (en) 1998-07-07 2011-02-01 Ritter Pharmaceuticals, Inc. Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
EP1492549A1 (en) * 2002-03-13 2005-01-05 Kibow Biotech, Inc. Compositions and methods for augmenting kidney function
EP1492549A4 (en) * 2002-03-13 2005-10-26 Kibow Biotech Inc Compositions and methods for augmenting kidney function
WO2004002501A1 (en) * 2002-06-26 2004-01-08 Calpis Co., Ltd. Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy
US8003092B2 (en) 2002-06-26 2011-08-23 Calpis Co., Ltd. Antiallergic agent, utilization thereof for reducing allergy and method of reducing allergy
WO2004017979A2 (en) * 2002-08-16 2004-03-04 Finzelberg Gmbh & Co. Kg Medicament, food supplement, and fodder additive
WO2004017979A3 (en) * 2002-08-16 2004-04-22 Finzelberg Gmbh & Co Kg Medicament, food supplement, and fodder additive
WO2004032645A1 (en) * 2002-10-11 2004-04-22 Erber Aktiengesellschaft Food additive and/or drinking water additive for domestic animals
AT413334B (en) * 2002-12-23 2006-02-15 Belihart Josephine Medically usable solid dosage form comprises freeze-dried live lactic acid bacteria and an excipient powder mixture of inulin and lactose in the form of a directly compressed tablet
FR2851889A1 (en) * 2003-03-06 2004-09-10 Larena Sa Product for restoration of tolerance to antigens useful for dietary or food compositions for prevention of intolerance to alimentary antigens and nonpathogenic bacteria and disturbance of the integrity of the intestinal barrier
EP1602377A1 (en) * 2003-03-07 2005-12-07 Aureo Co., Ltd. Composition containing beta-glucan and constipation-relieving drug, immunopotentiator and skin moistening agent using the composition
EP1602377A4 (en) * 2003-03-07 2009-06-24 Aureo Co Ltd Composition containing beta-glucan and constipation-relieving drug, immunopotentiator and skin moistening agent using the composition
WO2004112508A1 (en) * 2003-06-23 2004-12-29 Nestec S.A. Infant or follow-on formula
WO2004112507A1 (en) * 2003-06-23 2004-12-29 Nestec S.A. Infant or follow-on formula
EP1666050A1 (en) * 2003-08-26 2006-06-07 Obschestvo S Ogranichennoi Otvetstvennostyu Alef- Farma Use of enrerococcus faecium strains for curing hepatic insufficiency and for regenerating and intensifying metabolism in a liver
EP1666050A4 (en) * 2003-08-26 2008-01-09 Obschestvo S Ogranichennoi Otv Use of enrerococcus faecium strains for curing hepatic insufficiency and for regenerating and intensifying metabolism in a liver
US10172793B2 (en) 2003-12-24 2019-01-08 Ferrosan A.S. Probiotic tablet formulations
WO2005109175A3 (en) * 2004-05-05 2006-04-20 Lifescape Biosciences Inc Vitamin compositions and treatment methods for metabolic diseases and nutrient deficiencies
EP1607096A2 (en) * 2004-06-18 2005-12-21 Dietetics Pharma S.r.l. Nutraceutical composition containing milk enzymes useful as synbiotic
EP1607096A3 (en) * 2004-06-18 2006-01-04 Dietetics Pharma S.r.l. Nutraceutical composition containing milk enzymes useful as synbiotic
US7651680B2 (en) 2004-06-23 2010-01-26 L'oreal Methods and compositions for preventing and treating sensitive and dry skin
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
WO2006012536A3 (en) * 2004-07-22 2006-05-26 Andrew J Ritter Methods and compositions for treating lactose intolerance
US9226933B2 (en) 2004-07-22 2016-01-05 Ritter Pharmaceuticals, Inc. Methods and compositions for treating lactose intolerance
US8377482B2 (en) 2004-09-09 2013-02-19 Warburton Technology Limited Trace elements
WO2006027745A3 (en) * 2004-09-09 2006-05-11 Warburton Technology Ltd Trace elements
WO2006054135A1 (en) * 2004-11-16 2006-05-26 Anidral S.R.L. Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality
US9233130B2 (en) 2004-11-16 2016-01-12 Probiotical S.P.A. Probiotic bacteria based composition and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of the intestinal functionality
US8404228B2 (en) 2005-02-15 2013-03-26 Sherwood L. Gorbach Food containing a probiotic and an isolated β-glucan and methods of use thereof
US7981412B2 (en) 2005-02-15 2011-07-19 Gorbach Sherwood L Food containing a probiotic and an isolated β-glucan and methods of use thereof
EP2248430A3 (en) * 2005-02-15 2011-01-12 Barry R. Goldin A food containing a probiotic and an isolated beta-glucan and methods of use thereof
CN101262779B (en) * 2005-06-14 2011-04-13 爱尔伯股份公司 Probiotic health or fitness promoting foodstuff, feed, and/or drinking water additive and use thereof
AU2006257751B9 (en) * 2005-06-14 2011-04-07 Erber Aktiengesellschaft Probiotic health and performance promoting food, feed and/or drinking water additive and its use
WO2006133472A1 (en) * 2005-06-14 2006-12-21 Erber Aktiengesellschaft Probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive and use thereof
US8101170B2 (en) 2005-06-14 2012-01-24 Erber Aktiengesellschaft Probiotic health or fitness promoting human or animal foodstuff and/or drinking water additive and use thereof
AU2006257751B2 (en) * 2005-06-14 2011-03-31 Erber Aktiengesellschaft Probiotic health and performance promoting food, feed and/or drinking water additive and its use
EP2030642A4 (en) * 2006-05-26 2010-07-28 Serrano Jose Antonio Cruz Gelatinous protein foodstuff and process for its preparation
EP2030642A1 (en) * 2006-05-26 2009-03-04 José Antonio Cruz Serrano Gelatinous protein foodstuff and process for its preparation
WO2008071930A1 (en) 2006-12-11 2008-06-19 Danisco A/S Composition
EP1964570A1 (en) * 2007-03-02 2008-09-03 Bufe, Albrecht, Prof. Dr. med. Pharmaceutical compound to protect against allergies and inflammatory illnesses
US9950017B2 (en) 2007-03-02 2018-04-24 Forschungszentrum Borstel Pharmaceutical composition for protection from allergies and inflammatory disorders
US11154731B2 (en) 2007-09-04 2021-10-26 L'oreal Cosmetic use of Bifidobacterium species lysate for the treatment of dryness
US10238897B2 (en) 2007-09-04 2019-03-26 L'oreal Use of a lysate of bifidobacterium species for treating sensitive skin
WO2009071578A1 (en) * 2007-12-03 2009-06-11 Probiotical S.P.A. Composition based on probiotic bacteria in association with a prebiotic and use thereof in the prevention and/or treatment of respiratory pathologies and/or infections and in the improvement of intestinal functionality
US9758644B2 (en) 2008-07-18 2017-09-12 Roquette Freres Composition of soluble indigestible fibre and of microalgae used in the well-being field
US9725585B2 (en) 2008-07-18 2017-08-08 Roquette Freres Composition of soluble indigestible fibers and of eukaryotic organisms with a polysaccharide wall, used in the well-being field
FR2933848A1 (en) * 2008-07-18 2010-01-22 Roquette Freres COMPOSITION OF SOLUBLE INDIGESTIBLE FIBERS AND EUKARYOTIC ORGANISMS HAVING POLYSACCHARIDE WAVES USED IN THE WELL-BEING FIELD
US9375444B2 (en) 2008-08-16 2016-06-28 Protectimmun Gmbh Composition for prevention and treatment of allergic and/or inflammatory diseases
ITMI20090065A1 (en) * 2009-01-22 2010-07-23 Dietetics Pharma S R L NUTRACEUTICAL COMPOSITION CONTAINING USEFUL LACTICTS AS SYMBIOTIC.
US9579340B2 (en) 2009-02-24 2017-02-28 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8486668B2 (en) 2009-02-24 2013-07-16 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US9592248B2 (en) 2009-02-24 2017-03-14 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8492124B2 (en) 2009-02-24 2013-07-23 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US9775860B2 (en) 2009-02-24 2017-10-03 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US9808481B2 (en) 2009-02-24 2017-11-07 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8481299B2 (en) 2009-03-04 2013-07-09 L'oreal Use of probiotic microorganisms to limit skin irritation
US9049884B2 (en) 2009-12-04 2015-06-09 Abbott Laboratories Methods of modulating inflammation in preterm infants using carotenoids
ITMI20092327A1 (en) * 2009-12-29 2011-06-30 Giuliani Spa PHARMACEUTICAL OR DIETETIC COMPOSITION FOR THE TREATMENT OF ATOPIA
WO2012001640A1 (en) * 2010-06-29 2012-01-05 Rosebud Ag Prebiotic product and method for producing same
EP2401925A1 (en) * 2010-06-29 2012-01-04 Rosebud AG Prebiotic product and manufacturing method
WO2015160314A1 (en) * 2014-04-16 2015-10-22 SCHWARTZ, I. Sandford Nutraceutical blend for the enhancement of the immune system
WO2016035043A1 (en) * 2014-09-04 2016-03-10 SMITH, Jerome Shelsley Probiotic composition
WO2018020010A1 (en) * 2016-07-29 2018-02-01 Medday Pharmaceuticals Method for treating hepatic encephalopathy
US10117854B2 (en) 2016-07-29 2018-11-06 Medday Pharmaceuticals Method for treating hepatic encephalopathy
EP3275439A1 (en) * 2016-07-29 2018-01-31 Medday Pharmaceuticals Method for treating hepatic encephalopathy
US10328059B2 (en) 2016-07-29 2019-06-25 Medday Pharmaceuticals Method for treating hepatic encephalopathy
EP3318263A1 (en) * 2016-11-03 2018-05-09 Cell Biotech Co., Ltd. Antioxidant composition and composition for improvement of skin conditions
WO2022090335A1 (en) * 2020-10-28 2022-05-05 Dsm Ip Assets B.V. Direct delivery of vitamins to rebalance gut microbiome after exposure to antibiotics

Similar Documents

Publication Publication Date Title
DE20202562U1 (en) Micronutrient combination product with probiotics and prebiotics
Lillo-Pérez et al. Probiotics in fruit and vegetable matrices: Opportunities for nondairy consumers
CA2242107A1 (en) Multilayer tablet
AU2010281534B2 (en) Nutritional compositions comprising fiber and probiotics
JP2018027972A (en) Compositions and methods comprising pediococcus for reducing at least one symptom associated with autism spectrum disease in person diagnosed with autism spectrum disease
CN102124097B (en) Bacterial composition
Pereira et al. Turning fruit juice into probiotic beverages
EP1947962B1 (en) Edible product containing ginseng polysaccharides and beneficial bacteria
Salvetti et al. The genomic basis of lactobacilli as health-promoting organisms
JP2013507394A5 (en)
US9320767B2 (en) Extruded non-replicating probiotic micro-organisms and their health benefits
RU2011150197A (en) PROBIOTIC DIET ADDITIVE FOR ORAL ADMINISTRATION
CN103180432B (en) Prepare the method for shelf-stable probiotic food
TWI812587B (en) gel food composition
CA2477144A1 (en) Orally administrable composition for the photoprotection of the skin
CA2476619A1 (en) Pet food composition for skin photoprotection
Devi et al. Discrimination and divergence among Lactobacillus plantarum-group (LPG) isolates with reference to their probiotic functionalities from vegetable origin
Ozcan et al. The use of prebiotics of plant origin in functional milk products
Roy et al. Functional food: probiotic as health booster
KR20190001448A (en) Oval solid yogurt and method for manufacturing thereof
Lim et al. Current market trends and perspectives of probiotics
JP3407982B2 (en) Inoculant for fermented food
TWM639631U (en) Highly bioactive natural protein and peptide carrier structure
CN117481348A (en) Total nutrient formula powder applicable to tumors and preparation method thereof
WO2024026339A3 (en) Probiotic blend supplement with micronutrients for infant and children's health

Legal Events

Date Code Title Description
R207 Utility model specification

Effective date: 20020627

R150 Term of protection extended to 6 years

Effective date: 20050308

R151 Term of protection extended to 8 years

Effective date: 20080417

R158 Lapse of ip right after 8 years

Effective date: 20100901